 James Barry
Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neonatology | 4 | 2023 | 18 | 1.420 |
Why?
| | Intensive Care Units, Neonatal | 4 | 2021 | 178 | 0.950 |
Why?
| | Fetal Growth Retardation | 6 | 2016 | 468 | 0.890 |
Why?
| | Internship and Residency | 4 | 2022 | 1005 | 0.880 |
Why?
| | Crime | 1 | 2022 | 60 | 0.850 |
Why?
| | Intubation, Intratracheal | 2 | 2021 | 225 | 0.790 |
Why?
| | Physician Executives | 2 | 2019 | 37 | 0.790 |
Why?
| | Bradycardia | 1 | 2021 | 49 | 0.790 |
Why?
| | Clinical Competence | 5 | 2022 | 950 | 0.690 |
Why?
| | Patient Safety | 1 | 2022 | 281 | 0.680 |
Why?
| | Professional Role | 1 | 2019 | 151 | 0.620 |
Why?
| | Sheep | 7 | 2016 | 762 | 0.510 |
Why?
| | Pediatrics | 2 | 2013 | 980 | 0.510 |
Why?
| | Glucose | 3 | 2016 | 940 | 0.480 |
Why?
| | Delivery Rooms | 1 | 2012 | 7 | 0.430 |
Why?
| | Heart | 1 | 2016 | 630 | 0.410 |
Why?
| | Placental Insufficiency | 2 | 2009 | 104 | 0.370 |
Why?
| | Curriculum | 2 | 2013 | 908 | 0.360 |
Why?
| | Resuscitation | 1 | 2012 | 222 | 0.350 |
Why?
| | Insulin | 6 | 2016 | 2157 | 0.340 |
Why?
| | Placental Circulation | 1 | 2008 | 56 | 0.320 |
Why?
| | Pregnancy, Animal | 1 | 2007 | 57 | 0.300 |
Why?
| | Myocardium | 2 | 2016 | 965 | 0.280 |
Why?
| | Sheep, Domestic | 1 | 2006 | 32 | 0.280 |
Why?
| | Glucose Transporter Type 4 | 1 | 2006 | 38 | 0.280 |
Why?
| | Glucose Transporter Type 1 | 1 | 2006 | 42 | 0.280 |
Why?
| | Models, Animal | 1 | 2007 | 349 | 0.270 |
Why?
| | Hypoxia | 2 | 2009 | 957 | 0.260 |
Why?
| | Fellowships and Scholarships | 2 | 2019 | 250 | 0.230 |
Why?
| | Premedication | 1 | 2021 | 40 | 0.210 |
Why?
| | Medical Errors | 1 | 2022 | 88 | 0.200 |
Why?
| | Pregnancy | 8 | 2016 | 5671 | 0.190 |
Why?
| | Safety | 1 | 2022 | 304 | 0.190 |
Why?
| | Infant, Newborn | 6 | 2023 | 5230 | 0.180 |
Why?
| | Disease Models, Animal | 2 | 2009 | 3676 | 0.170 |
Why?
| | Brain Injuries | 1 | 2023 | 480 | 0.160 |
Why?
| | Prospective Studies | 4 | 2021 | 6443 | 0.160 |
Why?
| | Sepsis | 1 | 2023 | 531 | 0.150 |
Why?
| | Fetus | 4 | 2009 | 690 | 0.150 |
Why?
| | Students, Medical | 1 | 2022 | 311 | 0.150 |
Why?
| | Amino Acids | 3 | 2009 | 462 | 0.150 |
Why?
| | Educational Measurement | 2 | 2022 | 289 | 0.130 |
Why?
| | Glucose Clamp Technique | 1 | 2016 | 194 | 0.130 |
Why?
| | Obstetrics and Gynecology Department, Hospital | 1 | 2014 | 3 | 0.120 |
Why?
| | Female | 12 | 2019 | 61268 | 0.120 |
Why?
| | Humans | 13 | 2023 | 118268 | 0.120 |
Why?
| | Hospitals, University | 1 | 2014 | 172 | 0.120 |
Why?
| | Infant, Premature | 2 | 2014 | 479 | 0.110 |
Why?
| | Inservice Training | 1 | 2014 | 103 | 0.110 |
Why?
| | Infant, Premature, Diseases | 1 | 2014 | 91 | 0.110 |
Why?
| | Delivery, Obstetric | 1 | 2014 | 125 | 0.110 |
Why?
| | Fetal Development | 1 | 2016 | 250 | 0.110 |
Why?
| | Signal Transduction | 1 | 2006 | 4688 | 0.110 |
Why?
| | Advanced Cardiac Life Support | 1 | 2012 | 24 | 0.110 |
Why?
| | Surgical Procedures, Operative | 1 | 2014 | 214 | 0.100 |
Why?
| | Infant, Small for Gestational Age | 1 | 2012 | 73 | 0.100 |
Why?
| | Competency-Based Education | 1 | 2012 | 67 | 0.100 |
Why?
| | Animals | 8 | 2016 | 33152 | 0.100 |
Why?
| | Blood Glucose | 3 | 2009 | 1936 | 0.100 |
Why?
| | Hospitals, Pediatric | 1 | 2014 | 504 | 0.090 |
Why?
| | Data Collection | 1 | 2013 | 652 | 0.090 |
Why?
| | Gestational Age | 3 | 2009 | 765 | 0.090 |
Why?
| | Receptor, Insulin | 2 | 2007 | 100 | 0.090 |
Why?
| | Organ Size | 2 | 2009 | 460 | 0.080 |
Why?
| | Maternal-Fetal Exchange | 1 | 2009 | 156 | 0.080 |
Why?
| | Heart Rate | 1 | 2012 | 729 | 0.080 |
Why?
| | Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2007 | 16 | 0.080 |
Why?
| | Acidosis | 1 | 2009 | 84 | 0.080 |
Why?
| | Education, Medical, Graduate | 1 | 2012 | 399 | 0.080 |
Why?
| | Checklist | 2 | 2022 | 81 | 0.080 |
Why?
| | Lung Diseases | 1 | 2014 | 709 | 0.080 |
Why?
| | Computer Simulation | 1 | 2012 | 913 | 0.080 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 4684 | 0.070 |
Why?
| | Hypoglycemia | 2 | 2009 | 401 | 0.070 |
Why?
| | Oxygen | 2 | 2009 | 854 | 0.070 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 144 | 0.070 |
Why?
| | Regional Blood Flow | 1 | 2008 | 417 | 0.070 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2008 | 157 | 0.070 |
Why?
| | Insulin Receptor Substrate Proteins | 1 | 2006 | 59 | 0.070 |
Why?
| | Glycogen | 1 | 2006 | 59 | 0.070 |
Why?
| | Attitude of Health Personnel | 1 | 2013 | 991 | 0.070 |
Why?
| | Quality Improvement | 1 | 2013 | 962 | 0.070 |
Why?
| | Blood Pressure | 1 | 2012 | 1656 | 0.060 |
Why?
| | Fever | 1 | 2006 | 283 | 0.060 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2006 | 341 | 0.060 |
Why?
| | Phosphoproteins | 1 | 2006 | 303 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2006 | 418 | 0.060 |
Why?
| | Male | 5 | 2019 | 57479 | 0.060 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2006 | 403 | 0.060 |
Why?
| | Postoperative Complications | 1 | 2014 | 2230 | 0.060 |
Why?
| | Artificial Intelligence | 1 | 2023 | 137 | 0.050 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2023 | 124 | 0.050 |
Why?
| | Cohort Studies | 1 | 2012 | 5078 | 0.050 |
Why?
| | Body Weight | 1 | 2006 | 923 | 0.050 |
Why?
| | Placenta | 1 | 2007 | 637 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2022 | 2856 | 0.050 |
Why?
| | United States | 2 | 2014 | 12496 | 0.050 |
Why?
| | Transcription Factors | 1 | 2007 | 1567 | 0.040 |
Why?
| | Liver | 1 | 2007 | 1803 | 0.040 |
Why?
| | Muscle, Skeletal | 1 | 2008 | 1515 | 0.040 |
Why?
| | Middle Aged | 1 | 2019 | 27514 | 0.040 |
Why?
| | Random Allocation | 2 | 2009 | 344 | 0.040 |
Why?
| | Critical Care | 1 | 2022 | 488 | 0.040 |
Why?
| | Lactic Acid | 2 | 2009 | 278 | 0.040 |
Why?
| | Blotting, Western | 2 | 2008 | 1186 | 0.030 |
Why?
| | Manikins | 1 | 2014 | 26 | 0.030 |
Why?
| | Anesthesiology | 1 | 2014 | 39 | 0.030 |
Why?
| | Safety Management | 1 | 2014 | 109 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2014 | 234 | 0.030 |
Why?
| | Tertiary Care Centers | 1 | 2013 | 119 | 0.030 |
Why?
| | Survival Rate | 1 | 2014 | 1716 | 0.020 |
Why?
| | Infusion Pumps | 1 | 2009 | 32 | 0.020 |
Why?
| | Patient Care Team | 1 | 2014 | 521 | 0.020 |
Why?
| | Infusions, Parenteral | 1 | 2009 | 37 | 0.020 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2008 | 21 | 0.020 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2008 | 27 | 0.020 |
Why?
| | Somatostatin | 1 | 2008 | 53 | 0.020 |
Why?
| | Glucagon | 1 | 2009 | 98 | 0.020 |
Why?
| | Time Factors | 2 | 2009 | 6368 | 0.020 |
Why?
| | Chronic Disease | 1 | 2014 | 1631 | 0.020 |
Why?
| | Communication | 1 | 2014 | 754 | 0.020 |
Why?
| | Liver Glycogen | 1 | 2007 | 23 | 0.020 |
Why?
| | Oncogene Protein v-akt | 1 | 2007 | 25 | 0.020 |
Why?
| | Glucose-6-Phosphatase | 1 | 2007 | 32 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 154 | 0.020 |
Why?
| | Incidence | 1 | 2014 | 2413 | 0.020 |
Why?
| | Hyperinsulinism | 1 | 2008 | 107 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 528 | 0.020 |
Why?
| | Fetal Blood | 1 | 2009 | 270 | 0.020 |
Why?
| | Carbon Dioxide | 1 | 2009 | 230 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2007 | 541 | 0.020 |
Why?
| | Pancreas | 1 | 2009 | 281 | 0.020 |
Why?
| | Protein Kinases | 1 | 2008 | 306 | 0.020 |
Why?
| | Protein Biosynthesis | 1 | 2008 | 395 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2659 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2009 | 935 | 0.020 |
Why?
| | Down-Regulation | 1 | 2009 | 623 | 0.020 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2008 | 369 | 0.020 |
Why?
| | Dietary Supplements | 1 | 2009 | 468 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 980 | 0.020 |
Why?
| | Insulin-Secreting Cells | 1 | 2009 | 327 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2012 | 3156 | 0.020 |
Why?
| | Up-Regulation | 1 | 2007 | 862 | 0.020 |
Why?
| | Phosphorylation | 1 | 2007 | 1622 | 0.010 |
Why?
| | Child | 1 | 2022 | 19033 | 0.010 |
Why?
| | Algorithms | 1 | 2009 | 1522 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2007 | 2657 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2007 | 2435 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2012 | 12932 | 0.010 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2007 | 2159 | 0.010 |
Why?
|
|
Barry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|